Distribution of camptothecin-induced break points in Chinese hamster cells treated in late S and G2 phases of the cell cycle

Mutagenesis

Volumn 13, Issue 3, 1998, Pages 257-261

  Bassi, L ^a   Palitti, F ^a   Mosesso, P ^a   Natarajan, A T ^b  

^a UNIVERSITY OF TUSCIA   (Italy)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CLASTOGEN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHO CELL; CHROMATID; CHROMATIN CONDENSATION; CHROMOSOME BANDING PATTERN; CHROMOSOME DAMAGE; CHROMOSOME MAP; CHROMOSOME REPLICATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DNA SYNTHESIS; HETEROCHROMATIN; METAPHASE CHROMOSOME; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CAMPTOTHECIN; CELL LINE; CHROMOSOME BREAKAGE; COLCHICINE; CRICETINAE; FEMALE; G2 PHASE; S PHASE;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031747688     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/13.3.257     Document Type: Article

References (30)

1. 2: implications for the formation of chromosomal aberrations. Hereditas, 98, 61-64.
2. Andersson,H.C. and Kihlman,B.A. (1989) The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA. Carcinogenesis, 10, 123-130.
3. Andersson,H.C and Kihlman,B.A. (1992) Induction of chromosomal aberrations by camptothecin in root-tip cells of Vicia faba. Mutat. Res., 268, 167-181.
4. Balajee,A.S., Oh,H.J. and Natarajan,A.T. (1994) Analysis of restriction enzyme-induced chromosome aberrations in the interstitial telomeric repeat sequences of CHO and CHE cells by FISH. Mutat. Res., 307, 307-313.
5. D'Arpa,P. and Liu,F.L. (1989) Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta, 989, 163-177.
6. Degrassi,F., Salvia,R.D., Tanzarella,C. and Palitti,F. (1989) Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I. Mutat. Res., 211, 125-130.
7. Dillehay,L.E., Thompson,L.H., Minkler,J.L. and Carrano,A.V. (1983) The relationship between sister-chromatid exchange and perturbations in DNA replication in mutant EM9 and normal CHO cells. Mutat. Res., 109, 283-296.
8. Glisson,R.C. and Ross,W.E. (1987) DNA topoisomerase II: a primer on the enzyme and its unique role as multidrug target in cancer chemotherapy. Pharmac. Ther., 32, 89-106.
9. Hsiang,Y.-H., Lihou,M.G. and Liu,L.F. (1989) Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complex as a mechanism of cell killing by camptothecin. Cancer Res., 49, 5077-5082.
10. Palitti,F. (1993) Mechanism of induction of chromosomal aberrations by inhibitors of DNA topoisomerases. Environ. Mol. Mutagen., 22, 275-277.
11. 2 stage of the cell cycle. Mutat. Res., 110, 343-350.
12. 2. In Tice,R.R. and Hollaender,A. (eds), Sister Chromatid Exchanges. Plenum Press, New York, NY, pp. 313-319.
13. Palitti,F., Degrassi,F., De Salvia,R., Fiore,M. and Tanzarella,C. (1990) Inhibitors of DNA topoisomerases and chromosome aberrations. In Obe,G. and Natarajan,A.T. (eds), Chromosomal Aberrations: Basis and Applied Aspects. Springer Verlag, pp. 50-60.
14. 2 sensitivity to the induction of chromosomal damage in the CHO mutant EM9 than in its parental line AA8 by camptothecin, an inhibitor of DNA topoisomerase I. Mutat. Res., 285, 281-285.
15. Palitti,F., Mosesso,P., Dichiara,D., Schinoppi,A., Fiore,M. and Bassi,L. (1994) Use of anti-topoisomerase drugs to study the mechanisms of induction of chromosomal damage. In Obe,G. and Natarajan,A.T. (eds), Chromosomal Alterations: Origin and Significance. Springer Verlag, pp. 103-115.
16. Ross,W.E. (1985) DNA topoisomerases as targets for cancer therapy. Biochem. Pharmacol., 34, 4191-4195.
17. Ryan,A.J., Squires,S., Strutt,H.L. and Johnson,R.T. (1991) Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double-strand breaks in replicating DNA. Nucleic Acids Res., 19, 3295-3300.
18. Savage,J.R.K. (1976) Annotation: classification and relationship of induced chromosome structural changes. J. Med. Genet., 13, 103-122.
19. Savage,J.R.K. (1991) Testing the participation of chromosomes in structural aberrations. In Sobti,R.C. and Obe,G. (eds), Eukaryotic Chromosomes: Structural and Functional Aspects. Narosa, New Delhi, India, pp. 11-125.
20. Savage,J.R.K. and Papworth,D.G. (1982) Frequency and distribution studies of asymmetrical versus symmetrical chromosome aberrations. Mutat. Res., 95, 7-18.
21. Schmid,W. and Leppert,M.F. (1969) Rates of DNA synthesis in hetrochromatic and euchromatic segments of the chromosome complements of two rodents. Cytogenetics, 8, 125-135.
22. Scott,D., Galloway,S.M., Marshall,R.R., Ishidate,M.,Jr, Brusick,D, Ashby,J. and Myhr,B.C. (1991) Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutat. Res., 257, 147-204.
23. 1 exchange and terminal deletion breakpoints in Chinese hamster chromosomes as detected by G-bandmg. Int. J. Radiat. Biol., 66, 747-755.
24. 2 chromatid damage among Chinese hamster chromosomes: influence of caromatin conformation. Mutat. Res., 323, 113-119.
25. Smith,P.J. (1990) DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy. BioEssay, 12, 167-172.
26. 2 have nascent DNA with breaks between replicons and replication clusters. Exp. Cell Res., 129, 231.
27. Wang,J.C. (1985) DNA topoisomerases. Annu. Rev. Biochem., 54, 665-697.
28. Zhang,H., D'Arpa,P. and Liu,L.F. (1990) A model for tumour cell killing by topoisomerase poisons. Cancer Cells, 2, 23-27.
29. Zwelling,L.A. (1985) DNA topoisomerase II as a target of antineoplastic drug therapy. Cancer Metastasis Rev., 4, 263-276.
30. Zwelling,L.A., Michaels,S., Erickson,L.C., Ungerleider,R.S., Nichols,M. and Kohn,K.W. (1981) Protein-associated deoxyribonucleic acid intercalating agents 4′-(9-acridylamino)methanesulfon-m-anisidine and adriamycin. Biochemistry, 20, 6553-6563.